All In Biotech

Free tool

FAERS Monitor: Advil Pm

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021394 or its brand name (Advil Pm, Diphenhydramine Citrate, Ibuprofen). Reports on generic versions are filed under their own applications.

Reports

4,783

Serious

777

16% of reports

Hospitalization

190

Death reported

42

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,234
  • somnolence456
  • product use in unapproved indication346
  • drug effective for unapproved indication284
  • insomnia256
  • feeling abnormal230
  • dizziness197
  • fatigue195
  • intentional product misuse145
  • overdose131
  • headache121
  • nausea114
  • malaise109
  • incorrect dose administered104
  • drug effect incomplete101

Reports by year received

View as table
YearReports
200638
2007123
200856
200927
2010390
2011239
2012263
2013309
2014331
2015423
2016506
2017355
2018442
2019177
2020218
2021577
2022155
202360
202435
202531
202628

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,376 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug effective for unapproved indicationSignal28443.038.411,524
drug effect incompleteSignal10112.310.11,032
somnolenceSignal45610.09.13,702
intentional product misuseSignal1457.36.2783
product use in unapproved indicationSignal3466.15.61,501
insomniaSignal2564.23.8636
feeling abnormalSignal2304.23.7569
drug ineffectiveSignal1,2344.13.93,105
overdoseSignal1312.72.3137
incorrect dose administeredSignal1042.01.752
dizziness1971.71.562
fatigue1951.11.02
malaise1091.10.91
headache1210.80.73
nausea1140.60.525

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.